Biodegradable PLGA Microsphere Formation Mechanisms in Electrosprayed Liquid Droplets
Source abstract
Abstract
Microspheres composed of poly (lactic-co-glycolic acid) (PLGA) were formed in liquid droplets using the electrospray technique. The structure of the microspheres was controlled by changing the electric voltage of the electrospray. PLGA microspheres with porous structures and micro-sized nanocomposite particles comprising PLGA nanosphere aggregates were formed at 5.0–7.0 kV and 2.5–3.5 kV, respectively. The structural change was related to the extent of evaporation of the solvent from the droplets during their flight. When the evaporation was completed in the relatively small droplets, the microspheres with porous structures were formed in the droplets. To study the mechanism, we observed the effects of the electric voltage of the electrospray, PLGA concentration, flight distance of the droplets, and molecular weight of PLGA on the structure of the PLGA particles. The novelty of this study is the analysis of the size and structure of the PLGA microparticles, which were controlled by the electrospray technique. Therefore, this research has important implications for the structural design and preparation of nanocomposite particles.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrohydrodynamics and Fluid Dynamics · Pickering emulsions and particle stabilization · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Pharmaceutical/Beauty Science Research Center of the Hosokawa Micron Corporation, Japan
National Institute of Advanced Industrial Science and Technology (AIST), Japan
School of Pharmacy, Aichi Gakuin University, Japan
References (19)
Show source-provided references
1. Charlesworth D.H., Marshall Jr. W.R., Evaporation from drops containing dissolved solids, AIChE Journal, 6 (1960) 9–23. DOI: 10.1002/aic.69006010410.1002/aic.690060104 ↗
2. Hara K., Tsujimoto H., Tsukada Y., Huang C.C., Kawashima Y., Tsutsumi M., Histological examination of PLGA nanospheres for intratracheal drug administration, International Journal of Pharmaceutics, 356 (2008) 267–273. DOI: 10.1016/j.ijpharm.2007.12.04110.1016/j.ijpharm.2007.12.041 ↗
3. Kawashima Y., Imai M., Takeuchi H., Yamamoto H., Kamiya K., Development of agglomerated crystals of ascorbic acid by the spherical crystallization technique for direct tableting, and evaluation of their compactibilities [Translated], KONA Powder and Particle Journal, 20 (2002) 251–262. DOI: 10.14356/kona.200202810.14356/kona.2002028 ↗
4. Kawashima Y., Okumura M., Takenaka H., Spherical crystallization: direct spherical agglomeration of salicylic acid crystals during crystallization, Science, 216 (1982) 1127–1128. DOI: 10.1126/science.216.4550.112710.1126/science.216.4550.1127 ↗
5. Kawashima Y., Yamamoto H., Takeuchi H., Hino T., Niwa T., Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods, European Journal of Pharmaceutics and Biopharmaceutics, 45 (1998) 41–48. DOI: 10.1016/s0939-6411(97)00121-510.1016/S0939-6411(97)00121-5 ↗
6. Kimura S., Egashira K., Nakano K., Iwata E., Miyagawa M., Tsujimoto H., Hara K., Kawashima Y., Tominaga R., Sunagawa K., Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation, Circulation, 118 (2008) S65–S70. DOI: 10.1161/circulationaha.107.74061310.1161/CIRCULATIONAHA.107.740613 ↗
7. Kobara H., Nakatsuka K., Wakisaka A., Size-selected synthesis of metal nanoparticles by using electrospray in a liquid medium, Colloids and Surfaces A: Physicochemical and Engineering Aspects, 581 (2019) 123836. DOI: 10.1016/j.colsurfa.2019.12383610.1016/j.colsurfa.2019.123836 ↗
8. Mersmann A., Crystallization and precipitation, KONA Powder and Particle Journal, 16 (1998) 60–67. DOI: 10.14356/kona.199800910.14356/kona.1998009 ↗
9. Nakano K., Egashira K., Masuda S., Funakoshi K., Zhao G., Kimura S., Matoba T., Sueishi K., Endo Y., Kawashima Y., Hara K., Tsujimoto H., Tominaga R., Sunagawa K., Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries, JACC: Cardiovascular Interventions, 2 (2009) 277–283. DOI: 10.1016/j.jcin.2008.08.02310.1016/j.jcin.2008.08.023 ↗
10. Okada H., One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate, Advanced Drug Delivery Reviews, 28 (1997) 43–70. DOI: 10.1016/s0169-409x(97)00050-110.1016/S0169-409X(97)00050-1 ↗
11. Toguchi H., Ogawa Y., Okada H., Yamamoto M., Once-a-month injectable microcapsules of leuprorelin acetate, Yakugaku Zasshi, 111 (1991) 397–409. DOI: 10.1248/yakushi1947.111.8_39710.1248/yakushi1947.111.8_397 ↗
12. Tsujimoto H., Hara K., Huang C.C., Yokoyama T., Kawashima Y., The applications of biodegradable poly lactide-co-glycolide (PLGA) nano-spheres for pulmonary and transdermal drug deliveries, Foods & Food Ingredients Journal of Japan, 5 (2005) 437–448.
13. Tsujimoto H., Hara K., Tsukada Y., Huang C.C., Kawashima Y., Arakaki M., Okayasu H., Mimura H., Miwa N., Evaluation of the permeability of hair growing ingredient encapsulated PLGA nanospheres to hair follicles and their hair growing effects, Bioorganic & Medicinal Chemistry Letters, 17 (2007a) 4771–4777. DOI: 10.1016/j.bmcl.2007.06.05710.1016/j.bmcl.2007.06.057 ↗
14. Tsujimoto H., Hara K., Yokoyama T., Yamamoto H., Takeuchi H., Kawashima Y., Akagi K., Miwa N., Huang C.C., Percutaneous absorption study of biodegradable PLGA nano-spheres via human skin biopsies, Journal of the Society of Powder Technology, Japan, 41 (2004) 867–875. DOI: 10.4164/sptj.41.86710.4164/sptj.41.867 ↗
15. Tsujimoto H., Tsukada Y., Hara K., Kawashima Y., New particle design and its preparation of NFkB decoy oligodeoxynucleotide (NDON) loaded PLGA nanospheres for gene delivery, Journal of the Society of Powder Technology, Japan, 44 (2007b) 453–458. DOI: 10.4164/sptj.44.45310.4164/sptj.44.453 ↗
16. Tsukada Y., Hara K., Bando Y., Huang C.C., Kousaka Y., Kawashima Y., Morishita R., Tsujimoto H., Particle size control of poly(DL-lactide-co-glycolide) nanospheres for sterile applications, International Journal of Pharmaceutics, 370 (2009) 196–201. DOI: 10.1016/j.ijpharm.2008.11.01910.1016/j.ijpharm.2008.11.019 ↗
17. Yamamoto H., Hoshina W., Kurashima H., Takeuchi H., Kawashima Y., Yokoyama T., Tsujimoto H., Engineering of poly(DL-lactic-co-glycolic acid) nanocomposite particles for dry powder inhalation dosage forms of insulin with the spray-fluidized bed granulating system, Advanced Powder Technology, 18 (2007) 215–228. DOI: 10.1163/15685520778020859210.1163/156855207780208592 ↗
18. Yamamoto H., Kurashima H., Katagiri D., Yang M., Takeuchi H., Kawashima Y., Yokoyama T., Tsujimoto H., Poly (lactic-co-glycolic acid) nanosphere composite prepared with Mechanofusion® dry powder composition system for improving pulmonary insulin delivery with dry powder inhalation, Journal of Pharmaceutical Science and Technology, Japan, 64 (2004) 245–253. DOI: 10.14843/jpstj.64.24510.14843/jpstj.64.245 ↗
19. Yoshizawa H., Trends in microencapsulation research, KONA Powder and Particle Journal, 22 (2004) 23–31. DOI: 10.14356/kona.200400910.14356/kona.2004009 ↗